A Brief Bio of Dr. Baskaran Pillai
Dr. Baskaran Pillai is an Indian-born, naturalized U.S. citizen and a visionary scientist, spiritual leader, and biotech inventor. He earned his Ph.D. in Hinduism from the University of Pittsburgh in 1983, which laid the foundation for his pioneering neuroscience work. His fMRI brain-mapping studies at Harvard Medical School led to a U.S. patent for a brain enhancement device, now licensed to Vopec Pharmaceuticals for further research into neurotransmitter and hormonal modulation.
Dr. Pillai has invented dozens of novel small molecules in oncology and metabolic diseases. Among his innovations are two small molecules for Type 2 diabetes that have demonstrated superior efficacy in animal models compared to standard treatments like metformin and glipizide.
Commitment to Scientific Advancement in India
Dr. Pillai is committed to positioning Hinduism and Siddha medicine as advanced scientific systems, integrating them with modern biotechnology and quantum medicine. As part of this mission, he has allocated 52% of Vopec Pharmaceuticals’ revenue to remain in India, with the goal of developing India-based global health industries. Vopec plans to distribute its cancer drugs through government channels and accredited NGOs at cost, supporting equitable access.
Dr. Pillai is also the founder of AI:Intuit-Serendipity (AIIS), an emerging artificial intelligence framework that merges traditional Indian logic systems—such as Vitarka—with Western AI methodologies. This innovative platform underpins his drug discovery research and holds promise for broad scientific and technological applications.
A lifelong philanthropist, Dr. Pillai established the Tripura Foundation in the late 1990s to uplift underprivileged children and elders across India. His latest initiative, Cancer-Free India, seeks collaborative engagement with government bodies and nonprofit organizations to eradicate cancer through affordable, next-generation therapeutics.
A Brief Bio of Dr. Anbarasu Gowthamam
Dr. Gowtham is Chief Medical Officer and Research and Development Head at Vopec Pharmaceuticals. He holds an MBBS from India and an MS in Molecular Biotechnology from the University of Sydney, Australia. He is the Co-Founder of the East West Integrative Research Institute, established alongside Dr. Pillai, where he has led pioneering research in proteomics and small molecule drug discovery.
His work spans ground-breaking collaborative studies across the United States, Australia, and India, including with institutions such as World Care Clinical, Harvard University , Brain Science International, and Madras Medical College. Dr. Gowtham led the successful licensing of a topical psoriasis therapy from Vopec Pharmaceuticals to Lupin Pharmaceuticals.
Mr. Ramakrishnan Karnan
Siddha Ayurveda Head, Chief Operations Officer
As former General Manager of Astroved.com, Mr. Ramakrishnan Karnan spent a decade advancing traditional Vedic services to a global audience, a role he still advises on today. Today, Mr. Ramakrishnan Karnan is a champion of Vopec’s Siddha medicine. During the trying Covid times, he single-handedly managed our team around the clock to manufacture liquid Kabasura Kudineer (KSK) and a potent multi-herbal formulation, Amrta Karuna to expedite anti-viral and immune support to those in the greatest need.
Mr. Kannan
Advisor
Mr. Kannan is former Director of Drug Control, State of Tamil Nadu, India. His passion for Siddha Ayurveda medicines has built Vopec Pharmaceuticals manufacturing division. Under his stewardship, Vopec created over 200 Siddha Ayurveda formulation licenses to advance traditional medicine in Tamil Nadu.